Medici Brands
Medici Brands Raises $250M Series B for Food and Confectionery Brands
Medici Brands announced $250M in Series B financing on September 2, 2026. Medici Brands raised a $250 million Series B co-led by Greenoaks and Valor Equity Partners to expand David Protein and HallPass and launch new brands.
Round details
The financing includes backing from Greenoaks, Valor Equity Partners, ICONIQ, Imaginary Ventures, Peter Rahal. The company did not publish a valuation with the announcement.
- Round: Series B
- Capital announced: $250M
How the company plans to use the capital
Medici said the new capital will accelerate its next phase of growth, including expanding HallPass’ retail presence and product portfolio and extending David into new formats and categories. It will also fund product innovation and the infrastructure needed to launch and scale new brands such as Rowdy.
Why this matters for GTM teams
Greenoaks and Valor Equity Partners, which both invested in David’s $75 million Series A in 2025, co-led the round, and the statements from both firms quoted in the release refer to Medici’s technology.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Medici Brands Series B announcement.
Company Info
Investors (5)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


